Arguments Against the FDAs Decision: Potential Health Benefits: Advocates emphasize the reported benefits observed in animal studies and limited human use, arguing these should be weighed alongside regulatory concerns
However, anti-obesity medications are prescribed to only about 4% of eligible people due to concerns about safety or effectiveness, lack of health care provider training in weight management, excessive costs due to insurance companies refusing coverage, and a toxic stigma that portrays obesity as a lack of willpower
Semaglutide is a medication that mimics a hormone called glucagon-like peptide 1 , which the gut usually releases after eating
The FDA continues monitoring but has not issued a formal causality determination
Spencer Nadolsky about his involvement with Sequence, which eventually became WeightWatchers Clinic: I was the medical director for Sequence (now WeightWatchers Clinic) at the beginning
Ozempic och Wegovy innehller samma aktiva substans, semaglutid